Overview
PEG-MGF (PEGylated Mechano Growth Factor) is a chemically modified variant of Mechano Growth Factor, itself a splice variant of Insulin-like Growth Factor 1 (IGF-1). The addition of polyethylene glycol (PEG) chains extends the peptide's half-life from just minutes (native MGF) to several hours or days, dramatically improving its bioavailability and therapeutic window. PEG-MGF plays a critical role in muscle regeneration by activating satellite cells — the stem-cell-like precursors of muscle fibers — thereby supporting muscle repair, hypertrophy, and tissue recovery after mechanical stress or injury. It has also been studied for neuroprotective and cardioprotective effects.
Mechanism of Action
PEG-MGF activates satellite cells in muscle tissue via the IGF-1 receptor signaling pathway. When injected, it binds to IGF-1 receptors and triggers the PI3K/Akt/mTOR anabolic cascade, promoting protein synthesis and cell proliferation. Unlike systemic IGF-1, MGF acts primarily as a local tissue repair factor — it stimulates myoblast (muscle stem cell) division and fusion, a critical step in muscle fiber regeneration and hypertrophy. The PEGylation process attaches polyethylene glycol molecules to the peptide, shielding it from rapid enzymatic degradation and extending its biological half-life from approximately 5–7 minutes (native MGF) to 48–72 hours. PEG-MGF also regulates inflammation at injury sites by increasing neutrophil and macrophage recruitment, and it exhibits anti-apoptotic effects in damaged muscle cells. Additional research suggests PEG-MGF may enhance neural progenitor cell proliferation, promote cardiac stem cell survival, and improve bone marrow mesenchymal stem cell migration.
Potential Benefits
Activates muscle satellite cells to promote muscle fiber repair and growth Extends anabolic signaling window through PEGylation (hours vs minutes) Supports muscle hypertrophy when used post-training Enhances tissue regeneration at injury sites (tendons, ligaments, muscle) May reduce muscle recovery time after intense exercise Exhibits neuroprotective properties in preclinical models of cerebral ischemia May support cardiac muscle function via inhibition of apoptosis Does not suppress natural testosterone or affect HPTA axis
Dosage Protocols
The following reflects doses used in published research studies. This is not medical advice. Consult a qualified healthcare professional.
Beginner 150–200 mcg, 2x per week, post-workout Intermediate 200–400 mcg, 2–3x per week, post-workout Advanced 400–500 mcg, 3x per week, targeting specific muscle groups Cycle Duration 4–8 weeks (up to 16 weeks with gradual titration)
Inject within 30–60 minutes post-workout near the trained muscle group for localized effect. PEGylation allows once-daily or every-other-day systemic dosing. Start low and titrate upward every 2 weeks.
Use our Reconstitution Calculator to determine exact syringe units for your protocol.
Routes of Administration
Subcutaneous Injection High — PEGylation provides extended systemic circulation
Most common method. Inject near trained/injured muscle group for localized effect. Rotate injection sites to prevent tissue irritation or nodule formation.
Intramuscular Injection High — direct delivery to target muscle tissue
Preferred for site-specific targeting. Inject into the muscle group trained during the workout session for maximal satellite cell activation.
Read our full Routes of Administration Guide for detailed comparison of all delivery methods.
Stacking Protocols
Popular research stacks involving PEG-MGF:
Muscle Growth Stack
Combines PEG-MGF's satellite cell activation with IGF-1 LR3's sustained anabolic signaling and CJC-1295/Ipamorelin's growth hormone optimization. PEG-MGF 200–400 mcg post-workout 2–3x/week, IGF-1 LR3 50–100 mcg daily, CJC-1295 + Ipamorelin 100 mcg each before bed.
Injury Recovery Stack
Comprehensive tissue repair protocol. PEG-MGF near injury site 2–3x/week for satellite cell activation, BPC-157 250 mcg daily for angiogenesis and gut/tendon healing, TB-500 2–5 mg/week for systemic tissue remodeling.
Post-Cycle Recovery Stack
Preserves and rebuilds muscle tissue after anabolic cycles. PEG-MGF supports continued satellite cell activity while BPC-157 promotes healing and IGF-1 LR3 maintains anabolic drive.
Explore our complete Peptide Stacking Guide for more combinations and safety considerations.
Reconstitution
Storage Refrigerate at 2-8°C after reconstitution. Do not freeze reconstituted solution.
Typical vial sizes: 5 mg. Add bac water slowly down the side of the vial, swirl gently — do not shake. Use insulin syringe for precise dosing.
Amino Acid Sequence YQPPSTNKNTKSQRRKGSTFEEHK (MGF E peptide) + PEG modification
Side Effects & Safety
Injection site irritation (redness, swelling, mild discomfort) Fatigue or mild flu-like symptoms, especially at higher doses Localized muscle tightness or cramps Temporary water retention when stacked with GH-releasing peptides Potential blood pressure drop at excessive doses Hypoglycemia (low blood sugar) — rare Risk of disproportionate muscle growth if repeatedly injected at same site
Safety & Contraindications
This information is for educational purposes only. Consult a qualified healthcare provider before using any peptide.
Absolute
Active Malignancy
Relative
Pregnancy / Lactation
Relative
Bleeding Disorders
Absolute
Active Skin Infection at Injection Site
Pharmacokinetics
Half-Life ~48-72 hours (vs ~5-7 min for native MGF) Storage Store lyophilized peptide at -20°C (long-term) or 2-8°C (short-term, under 30 days). Reconstituted: refrigerate at 2-8°C and use within 28-30 days. Protect from light. Do not freeze reconstituted solution.
Synergistic Compounds
The following compounds have been studied alongside PEG-MGF for potential complementary or synergistic effects:
Learn More
References & Further Reading
Mechano Growth Factor splice variant of IGF-I promotes myoblast proliferationYang SY, Goldspink G. Journal of Muscle Research and Cell Motility. 2002 Expression of MGF isoforms following exercise and muscle damageHill M, Goldspink G. Molecular and Cellular Endocrinology. 2003 PEGylation enhances the therapeutic potential of MGF for muscle regenerationCarpenter V et al.. Growth Hormone & IGF Research. 2008 MGF promotes neural progenitor cell proliferation and neuroprotectionDluzniewska J et al.. Experimental Cell Research. 2005